All In MedTech

FDA Clearance Tracker · P050051-S050

ARCHITECT AUSAB

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 19, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P050051-S050
Device name
ARCHITECT AUSAB
Applicant location
Abbott Park, IL
Received
May 1, 2023
Decided
Jan 19, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P050051

Device type

Device class
Class II
Regulation
21 CFR 866.3172

Every decision under product code LOM

FDA's approval statement

As written in FDA's record.

Approval for the migration of ARCHITECT AUSAB (Mag/Sep) from the ARCHITECT i2000SR to the ARCHITECT i1000SR system.

Source documents

Other decisions for Abbott Laboratories, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.